Session » (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Date: Tuesday, October 28, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 1802

Clearance Kinetics and Cartilage Retention of MM-II, a Dispersion of Large Empty Liposomes, in Rat Knees

10:30AM-12:30PM: Abstract Number: 1791

Determining the Effect of CD14 Deficiency on Osteoblastogenesis and Subchondral Bone Remodeling In Mice

10:30AM-12:30PM: Abstract Number: 1805

Human meniscus histopathological and transcriptomic changes at early and advanced stages of knee osteoarthritis

10:30AM-12:30PM: Abstract Number: 1808

Lightsheet imaging with 3D analysis for wholistic assessment of synovial lymphatic vasculature within joints of murine models of arthritis

10:30AM-12:30PM: Abstract Number: 1788

Manganese-associated Single-nucleotide Polymorphisms are Associated with Radiographic Knee Osteoarthritis: The Johnston County Osteoarthritis Project

10:30AM-12:30PM: Abstract Number: 1782

Mapping The Synovial Innervation Of The Human Knee Joint

10:30AM-12:30PM: Abstract Number: 1801

Matrikine Activation of Synovial Fibroblasts Promotes Monocyte Migration and Stimulates an OA Chondrocyte Phenotype

10:30AM-12:30PM: Abstract Number: 1780

Modeling Osteoarthritis Knee Joint in a Compartmentalized Microfluidic System using IPSC-derived Sensory Neurons and human Synovial Fibroblasts

10:30AM-12:30PM: Abstract Number: 1796

Multi-Tissue Molecular and Histopathological Profiling of Facet Joints and Intervertebral Discs

10:30AM-12:30PM: Abstract Number: 1784

Multimodal Preclinical Screening Of Glucocorticoid-Induced Disruption Of Bone Remodeling In Rat

10:30AM-12:30PM: Abstract Number: 1783

Nerve Growth Factor Causes Sensitization, Nociceptor Sprouting, Synovitis, And Osteophyte Formation In Naïve Murine Joints

10:30AM-12:30PM: Abstract Number: 1792

OA protection in African spiny (Acomys) mice is partially mediated by the gut microbiome and is transferrable to wild-type mice via microbiome transplantation

10:30AM-12:30PM: Abstract Number: 1794

OA-associated pain sensitivity is reduced in OA-protected MRL/MpJ mice, partially mediated by the gut microbiome, and transferable via microbiome transplantation

10:30AM-12:30PM: Abstract Number: 1803

Patching of Damaged Meniscus and Cartilage of Osteoarthritic Animals by MM-II, a Dispersion of Empty Large Multilamellar Liposomes

10:30AM-12:30PM: Abstract Number: 1804

Pharmacology of LEVI-04, a novel treatment for OA

10:30AM-12:30PM: Abstract Number: 1798

Proteomic Profiling of Chondrogenic Gene Therapy in Human MSCs Reveals Distinct Regenerative Pathways for Articular Cartilage Repair

10:30AM-12:30PM: Abstract Number: 1797

SEV-101 Exosomes Isolated from Induced Pluripotent Stem Cell – Derived Hyaline Cartilage Tissue – Characterization of Immunomodulatory and Chondro-proliferative Effects In Vitro

10:30AM-12:30PM: Abstract Number: 1786

SEV-101, A Regenerative Exosome Therapeutic for the Treatment of Osteoarthritis

10:30AM-12:30PM: Abstract Number: 1806

Sex differences in knee joint microbial DNA of C57BL/6 mice and the effect of cross-sex microbiome transplantation

10:30AM-12:30PM: Abstract Number: 1793

Sex-associated changes to synovial macrophages in the aging joint

10:30AM-12:30PM: Abstract Number: 1785

Soluble CD14 Amplifies Chondrocyte Inflammatory Responses to Lipopolysaccharide and Is Targetable by Anti-CD14 Therapy

10:30AM-12:30PM: Abstract Number: 1789

Spatial Analysis of Advanced Osteoarthritis Synovial Tissue

10:30AM-12:30PM: Abstract Number: 1787

Spatial and Quantitative Semiautomated Image Analysis of Synovial Biopsies Studied Using a Novel High-Plex Immunofluorescence Platform

10:30AM-12:30PM: Abstract Number: 1781

Specific gut microbiome remodeling occurs after induction of OA via DMM surgery compared to sham surgery

10:30AM-12:30PM: Abstract Number: 1790

Targeted Ablation of Knee-innervating Nociceptors Attenuates Pain and Cartilage Degeneration in Experimental Osteoarthritis

10:30AM-12:30PM: Abstract Number: 1800

The Role of Nociceptor-Expressed Piezo2 in Nervous System Immune Cell Infiltration in a Mouse Model of Osteoarthritis

10:30AM-12:30PM: Abstract Number: 1795

Trends and Disparities in Osteoarthritis-Related Mortality in the United States: A 21-Year Analysis (1999-2020)

10:30AM-12:30PM: Abstract Number: 1799

Validating the Gouty Arthritis Alleviating Effects of Cerevisterol through Integrated In Silico, In Vitro, and In Vivo Studies

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].